The effect of aspirin on aneurysm wall enhancement: A study in rabbits and humans

Abstract

Objective

Aneurysm wall enhancement (AWE) is a potential biomarker of inflammation within the aneurysm wall that has been correlated with a higher risk of rupture. Aspirin (ASA) may decrease AWE due to its anti-inflammatory properties. We aimed to assess the effect of ASA on AWE in an animal model and a cohort of patients with unruptured intracranial aneurysms (UIAs).

Methods

Three rabbits with elastase-induced aneurysms were exposed to ASA for 8 weeks and three rabbits were used as controls. 3 T high-resolution magnetic resonance imaging (HR-MRI) was performed at 7 days and 8 weeks to evaluate changes in AWE through histological and immunohistological analyses. Additionally, we evaluated AWE in patients who underwent imaging with a 3 T HR-MRI protocol. ASA exposure was defined as daily intake of 81 mg for at least six months prior to HR-MRI. AWE was quantified using three-dimensional AWE maps and histograms.

Results

Among rabbits exposed to ASA, the mean AWE was lower at 8 weeks compared to the controls (2.11 vs 2.15, p = 0.13). Immunostaining of the aneurysm wall in rabbits that received ASA revealed a reduced expression of CD68 + or cyclooxygenase-2 + cells, compared to the controls. A total of 99 patients with 120 UIAs were included in the HR-MRI analysis of UIAs. UIAs exposed to ASA (22/120) had significantly lower median AWE than those that were not exposed (0.60 vs 0.72, p = 0.032).

Conclusion

ASA therapy is associated with an objective reduction in AWE, suggesting a potential role in lowering the risk of aneurysm rupture.

Keywords

Inflammation macrophages subarachnoid hemorrhage vessel wall imaging

Get full access to this article

View all access options for this article.

References

Ajiboye

Chalouhi

Starke

, et al. Unruptured cerebral aneurysms: evaluation and management. Sci World J 2015; 2015: 954954.

Chung

Peterson

Howard

, et al. Imaging intracranial aneurysms in the endovascular era: surveillance and posttreatment follow-up. Radiographics 2022; 42: 789–805.

Thompson

Brown

Jr. Amin-Hanjani

, et al. Guidelines for the management of patients with unruptured intracranial aneurysms: a guideline for healthcare professionals from the American Heart Association/American stroke association. Stroke 2015; 46: 2368–2400.

Etminan

de Sousa

Tiseo

, et al. European Stroke Organisation (ESO) guidelines on management of unruptured intracranial aneurysms. Eur Stroke J 2022; 7: V. doi: https://doi.org/10.1177/23969873221099736

Chalouhi

Ali

Jabbour

, et al. Biology of intracranial aneurysms: role of inflammation. J Cereb Blood Flow Metab 2012; 32: 1659–1676.

Guo

Zhao

, et al. Aspirin and growth, rupture of unruptured intracranial aneurysms: a systematic review and meta-analysis. Clin Neurol Neurosurg 2021; 209: 106949.

Weng

Wang

, et al. Safety of aspirin use in patients with stroke and small unruptured aneurysms. Neurology 2021; 96: e19–e29.

Weng

Wang

, et al. Aspirin and growth of small unruptured intracranial aneurysm: results of a prospective cohort study. Stroke 2020; 51: 3045–3054.

Mossa-Basha

Zhu

Yuan

, et al. Survey of the American society of neuroradiology membership on the use and value of intracranial vessel wall MRI. AJNR Am J Neuroradiol 2022; 43: 951–957.

10.

Molenberg

Aalbers

Appelman

APA

, et al. Intracranial aneurysm wall enhancement as an indicator of instability: a systematic review and meta-analysis. Eur J Neurol 2021; 28: 3837–3848.

11.

Peng

Xia

, et al. Quantification of aneurysm wall enhancement in intracranial fusiform aneurysms and related predictors based on high-resolution magnetic resonance imaging: a validation study. Ther Adv Neurol Disord 2022; 15: 17562864221105342.

12.

Roa

Zanaty

Ishii

, et al. Decreased contrast enhancement on high-resolution vessel wall imaging of unruptured intracranial aneurysms in patients taking aspirin. J Neurosurg 2020; 134: 902–908.

13.

Tutino

Rajabzadeh-Oghaz

Veeturi

, et al. Endogenous animal models of intracranial aneurysm development: a review. Neurosurg Rev 2021; 44: 2545–2570.

14.

Cloft

Altes

Marx

, et al. Endovascular creation of an in vivo bifurcation aneurysm model in rabbits. Radiology 1999; 213: 223–228.

15.

Dai

Ding

Danielson

, et al. Histopathologic and immunohistochemical comparison of human, rabbit, and swine aneurysms embolized with platinum coils. AJNR Am J Neuroradiol 2005; 26: 2560–2568.

16.

Hasan

Chalouhi

Jabbour

, et al. Evidence that acetylsalicylic acid attenuates inflammation in the walls of human cerebral aneurysms: preliminary results. J Am Heart Assoc 2013; 2: e000019.

17.

Fedorov

Beichel

Kalpathy-Cramer

, et al. 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging 2012; 30: 1323–1341.

18.

Raghuram

Varon

Roa

, et al. Semiautomated 3D mapping of aneurysmal wall enhancement with 7T-MRI. Sci Rep-Uk 2021; 11. doi: http://dx.doi.org/10.1038/s41598-021-97727-0

19.

Dhar

Tremmel

Mocco

, et al. Morphology parameters for intracranial aneurysm rupture risk assessment. Neurosurgery 2008; 63: 185–196.

20.

Ujiie

Tamano

Sasaki

, et al.

Is the aspect ratio a reliable index for predicting the rupture of a saccular aneurysm?

Neurosurgery 2001; 48: 495–502.

21.

Sho

Singh

, et al. Arterial enlargement in response to high flow requires early expression of matrix metalloproteinases to degrade extracellular matrix. Exp Mol Pathol 2002; 73: 142–153.

22.

Fisher

Demel

. Nonsteroidal anti-inflammatory drugs: a potential pharmacological treatment for intracranial aneurysm. Cerebrovasc Dis Extra 2019; 9: 31–45.

23.

Shimonaga

Matsushige

Ishii

, et al. Clinicopathological insights from vessel wall imaging of unruptured intracranial aneurysms. Stroke 2018; 49: 2516–2519.

24.

Galex

Sadeghi

, et al. Rabbit elastase aneurysm: imaging and histology correlates for inflammation and healing. World Neurosurg 2021; 148: e242–e251.

25.

Wanderer

Grüter

Strange

, et al. Aspirin treatment prevents inflammation in experimental bifurcation aneurysms in New Zealand white rabbits. J Neurointerv Surg 2022; 14: 189–195.

26.

Suzuki

Kamio

Makino

, et al. Prevention effect of antiplatelets on aneurysm rupture in a mouse intracranial aneurysm model. Cerebrovasc Dis 2018; 45: 180–186.

27.

Raghuram

Sanchez

Wendt

, et al. 3D Aneurysm wall enhancement is associated with symptomatic presentation. J Neurointerv Surg 2023; 15: 747–752.

28.

Wang

Xia

Liu

, et al. The relationship of arterial wall enhancement ratio on MRI with the degree of inflammation in a rabbit aneurysm model: a pilot study. Acad Radiol 2019; 26: e292–e297.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.02 MB